SK Archives | Page 2 of 8 | Be Korea-savvy
SK E&C Launches Demonstration Project for Carbon Emission-free Hydrogen Fuel Cell Power Generation

SK E&C Launches Demonstration Project for Carbon Emission-free Hydrogen Fuel Cell Power Generation

SEOUL, April 30 (Korea Bizwire) – SK Engineering & Construction Co., a leading South Korean builder, has launched a demonstration project for carbon emission-free hydrogen fuel cell power generation. The company announced that it will establish a pure hydrogen solid oxide fuel cell (SOFC) power generation facility in collaboration with its affiliate SK Advanced Co., [...]

SK Innovation Subsidiary to Invest 1 tln Won on Lithium-ion Battery Separators

SK Innovation Subsidiary to Invest 1 tln Won on Lithium-ion Battery Separators

SEOUL, March 29 (Korea Bizwire) — SK IE Technology Co. (SKIET), an affiliate of South Korean EV battery producer SK Innovation Co., has decided to make a large investment to preempt the fledgling market for lithium-ion battery separators. The company decided to invest an unprecedented 1.13 trillion won (US$997 million) to build its third and [...]

SK Holdings Makes Foray into Power Semiconductors Market

SK Holdings Makes Foray into Power Semiconductors Market

SEOUL, Jan. 29 (Korea Bizwire) — SK Holdings Co., the holding firm of South Korean energy and telecom conglomerate SK Group, is moving into the silicon carbide (SiC) power semiconductor market. SiC power semiconductors are one of the core components of electric vehicles and hydrogen fuel-cell automobiles. The firm announced on Thursday that it had [...]

SK to Invest $200 mln in Roivant’s Targeted Protein Degradation Platform

SK to Invest $200 mln in Roivant’s Targeted Protein Degradation Platform

SEOUL, Dec. 7 (Korea Bizwire) — SK Holdings Co., an investment arm of South Korean conglomerate SK Group, said Monday it has signed a strategic partnership deal with U.S. biopharmaceutical firm Roivant Sciences Ltd. to enter the targeted protein degradation drug market. Under the deal, SK will invest US$200 million into Roivant’s targeted protein degradation [...]